November 23, 2016. Actress Elisabeth Rohm urges you to join us and fight cancer in her new public service announcement.
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
This Tiny Plastic Implant May Disrupt America’s Opioid Addiction Problem
Motherboard by Vice, November 15, 2016. “I think the big issue is the transition,” said Diana Zuckerman, NCHR President, who was not involved with the trials. “People are going to go from taking pills to using this implant. The implant doesn’t work immediately. It takes a while for it to work and settle into the level that it’s supposed to be. And during that time the person is still going to be taking pills, and that becomes a vulnerable time. How many pills should that person take before the implant is really working, and should they continue to take pills after it’s working?“
Read More »Lowering the Bar: How PMDD Went from an Idea to a Diagnosis
MedPage Today, November 16, 2016. “Safer drugs are available to effectively treat PMDD,” Diana Zuckerman, NCHR President, said. “How bad is your PMDD that you are willing to put your life at risk?”
Read More »FDA Hearing on Off-Labels Use of Devices Explores Risks to Patients
Star Tribune, November 10, 2016. NCHR President Diana Zuckerman said the Infuse Bone Graft is “contraindicated” for children. But the FDA’s 2015 warning didn’t ban the product in kids because some children have such significant bone defects or such rare bone disorders that they would be willing to accept the risks.
Read More »Trump Just Dropped a Big Hint to the Pharmaceutical Industry
Washington Post, November 14, 2016. “I think the honest answer is nobody knows” what to expect, said Diana Zuckerman, president of the National Center for Health Research. “Some members of Congress owe pharma a favor; we don’t know the Trump campaign is in that position, and they might not be — and that might give them a certain amount of flexibility. The Trump campaign is nothing if not iconoclastic.”
Read More »